PHC Holdings Corporation

TSE:6523 Stock Report

Market Cap: JP¥121.7b

PHC Holdings Valuation

Is 6523 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6523 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6523 (¥965) is trading below our estimate of fair value (¥1720.24)

Significantly Below Fair Value: 6523 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6523?

Key metric: As 6523 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6523. This is calculated by dividing 6523's market cap by their current revenue.
What is 6523's PS Ratio?
PS Ratio0.3x
SalesJP¥360.94b
Market CapJP¥121.72b

Price to Sales Ratio vs Peers

How does 6523's PS Ratio compare to its peers?

The above table shows the PS ratio for 6523 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.8x
7817 Paramount Bed Holdings
1.4x6.7%JP¥145.1b
7575 Japan Lifeline
1.7x3.6%JP¥92.5b
7716 Nakanishi
2.6x5.1%JP¥195.4b
6960 Fukuda Denshi
1.5x3.8%JP¥208.7b
6523 PHC Holdings
0.3x1.4%JP¥121.7b

Price-To-Sales vs Peers: 6523 is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (1.8x).

Price to Sales Ratio vs Industry

How does 6523's PS Ratio compare vs other companies in the JP Medical Equipment Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
7702 JMSLtd
0.2xn/aUS$70.98m
3604 Kawamoto
0.1xn/aUS$30.32m
No more companies available in this PS range
6523 0.3xIndustry Avg. 1.6xNo. of Companies5PS01.22.43.64.86+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 6523 is good value based on its Price-To-Sales Ratio (0.3x) compared to the JP Medical Equipment industry average (1.6x).

Price to Sales Ratio vs Fair Ratio

What is 6523's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6523 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio1.3x

Price-To-Sales vs Fair Ratio: 6523 is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6523 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥965.00
JP¥1,036.67
+7.4%
11.2%JP¥1,200.00JP¥870.00n/a6
Nov ’25JP¥999.00
JP¥1,071.67
+7.3%
6.8%JP¥1,200.00JP¥980.00n/a6
Oct ’25JP¥1,055.00
JP¥1,071.67
+1.6%
6.8%JP¥1,200.00JP¥980.00n/a6
Sep ’25JP¥1,150.00
JP¥1,071.67
-6.8%
6.8%JP¥1,200.00JP¥980.00n/a6
Aug ’25JP¥1,110.00
JP¥1,060.00
-4.5%
8.5%JP¥1,200.00JP¥910.00n/a6
Jul ’25JP¥1,172.00
JP¥1,087.14
-7.2%
10.4%JP¥1,200.00JP¥860.00n/a7
Jun ’25JP¥1,096.00
JP¥1,101.43
+0.5%
10.9%JP¥1,200.00JP¥860.00n/a7
May ’25JP¥1,159.00
JP¥1,200.00
+3.5%
10.0%JP¥1,400.00JP¥1,000.00n/a7
Apr ’25JP¥1,236.00
JP¥1,242.86
+0.6%
14.8%JP¥1,600.00JP¥1,000.00n/a7
Mar ’25JP¥1,212.00
JP¥1,414.29
+16.7%
20.2%JP¥2,000.00JP¥1,100.00n/a7
Feb ’25JP¥1,525.00
JP¥1,580.00
+3.6%
16.9%JP¥2,000.00JP¥1,200.00n/a7
Jan ’25JP¥1,437.00
JP¥1,572.86
+9.5%
16.6%JP¥2,000.00JP¥1,200.00n/a7
Dec ’24JP¥1,480.00
JP¥1,644.29
+11.1%
13.0%JP¥2,000.00JP¥1,300.00n/a7
Nov ’24JP¥1,423.00
JP¥1,662.86
+16.9%
12.6%JP¥2,000.00JP¥1,300.00JP¥999.007
Oct ’24JP¥1,526.00
JP¥1,684.29
+10.4%
13.6%JP¥2,000.00JP¥1,300.00JP¥1,055.007
Sep ’24JP¥1,440.00
JP¥1,684.29
+17.0%
13.6%JP¥2,000.00JP¥1,300.00JP¥1,150.007
Aug ’24JP¥1,518.00
JP¥1,724.29
+13.6%
12.7%JP¥2,050.00JP¥1,400.00JP¥1,110.007
Jul ’24JP¥1,541.00
JP¥1,767.14
+14.7%
17.2%JP¥2,400.00JP¥1,400.00JP¥1,172.007
Jun ’24JP¥1,490.00
JP¥1,767.14
+18.6%
17.2%JP¥2,400.00JP¥1,400.00JP¥1,096.007
May ’24JP¥1,434.00
JP¥1,821.43
+27.0%
15.7%JP¥2,400.00JP¥1,500.00JP¥1,159.007
Apr ’24JP¥1,432.00
JP¥1,885.71
+31.7%
14.8%JP¥2,400.00JP¥1,500.00JP¥1,236.007
Mar ’24JP¥1,431.00
JP¥1,885.71
+31.8%
14.8%JP¥2,400.00JP¥1,500.00JP¥1,212.007
Feb ’24JP¥1,525.00
JP¥2,128.57
+39.6%
20.4%JP¥3,000.00JP¥1,600.00JP¥1,525.007
Jan ’24JP¥1,473.00
JP¥2,164.29
+46.9%
20.1%JP¥3,000.00JP¥1,600.00JP¥1,437.007
Dec ’23JP¥1,545.00
JP¥2,171.43
+40.5%
19.6%JP¥3,000.00JP¥1,650.00JP¥1,480.007
Nov ’23JP¥1,569.00
JP¥2,128.57
+35.7%
16.4%JP¥2,700.00JP¥1,650.00JP¥1,423.007

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

TOWA Hi SYSTEMLTD

JP¥4.1b

Develops medical software solutions in Japan.

4172

JP¥1,843.00

7D

-0.4%

1Y

15.8%

FINDEX

JP¥19.9b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥777.00

7D

-2.9%

1Y

-18.6%

TOKAI

JP¥72.0b

Provides various healthy life services in Japan.

9729

JP¥2,130.00

7D

-3.3%

1Y

10.9%